Search this site:
STATEMENT PURSUANT TO ARTICLE 84-bis OF CONSOB REGULATION N. 11971/99
Milan, July 31st, 2014 – Sorin Group communicates that, pursuant to art. 84-bis of Consob ...
SORIN GROUP ANNOUNCES RESULTS FOR THE SECOND QUARTER OF 2014
Consolidated results for the second quarter of 2014: Revenues were €190.6 million, ...
SORIN GROUP ANNOUNCES FDA APPROVAL OF SOLO SMART – THE NEXT EVOLUTION IN TISSUE VALVE TECHNOLOGY
Solo Smart is the first aortic valve with a removable stent, providing native-like performance ...
Cardiac Rhythm Management
Working at Sorin
Wake up your talent
Check for jobs